Author Interviews, Breast Cancer, Cancer Research, JAMA, MRSA, Radiation Therapy / 06.05.2023
Bacterial Decolonization Reduced Radiation Dermatitis in Patients with Nasal Staphylococcus aureus
MedicalResearch.com Interview with:
[caption id="attachment_60394" align="alignleft" width="150"]
Dr. McLellan[/caption]
Beth McLellan, M.D.
Chief, Division of Dermatology
Montefiore Medical Center
Albert Einstein College of Medicine
MedicalResearch.com: What is the background for this study? How is the decolonization initiated and maintained?
Response: We were interested in exploring whether bacteria on the skin plays a role in radiation dermatitis like it does in other skin diseases that cause a breakdown in the skin barrier. We used a bacterial decolonization regimen that includes chlorhexidine 2% cleanser for the body and mupirocin 2% ointment to the inside of the nose for 5 consecutive days before starting radiation therapy and repeated for an additional 5 days every other week for the duration of radiation.
Dr. McLellan[/caption]
Beth McLellan, M.D.
Chief, Division of Dermatology
Montefiore Medical Center
Albert Einstein College of Medicine
MedicalResearch.com: What is the background for this study? How is the decolonization initiated and maintained?
Response: We were interested in exploring whether bacteria on the skin plays a role in radiation dermatitis like it does in other skin diseases that cause a breakdown in the skin barrier. We used a bacterial decolonization regimen that includes chlorhexidine 2% cleanser for the body and mupirocin 2% ointment to the inside of the nose for 5 consecutive days before starting radiation therapy and repeated for an additional 5 days every other week for the duration of radiation.
Prof. Mainous[/caption]
Arch G. Mainous III, PhD
Professor
Department of Health Services Research, Management and Policy
Professor and Vice Chair for Research
Department of Community Health and Family Medicine
University of Florida
MedicalResearch.com: What is the background for this study?
Response: We are always concerned about infections from antibiotic resistant bacteria. When the bacteria are resistant to our current treatments this lengthens the time and severity of the illness. Staphylococcus aureus is a major cause of community and healthcare associated infections. These range from skin infections to invasive infections and even death. Methicillin-resistant S. aureus (MRSA) is of particular concern and is a burden on the health care system. Importantly, patients colonized, not infected, with MRSA are more likely to develop MRSA infections and patients with MRSA infections have increased risk of hospital length of stay and even death.
We are always concerned about infections from antibiotic resistant bacteria. When the bacteria are resistant to our current treatments this lengthens the time and severity of the illness. Staphylococcus aureus is a major cause of community and healthcare associated infections. These range from skin infections to invasive infections and even death. Methicillin-resistant S. aureus (MRSA) is of particular concern and is a burden on the health care system. Importantly, patients colonized, not infected, with MRSA are more likely to develop MRSA infections and patients with MRSA infections have increased risk of hospital length of stay and even death.






